## Abstract __HERβ2/NEU__ is one of the most frequently amplified oncogenes and a potential therapeutic target in bladder cancer. In breast cancer, the adjacent __TOP2A__ gene, the molecular target for several anticancer drugs, is frequently coamplified together with __HERβ2__. To study the amplifi
HER-2, TOP2A and chromosome 17 alterations in breast cancer
β Scribed by Asli Rehber Beser; Sitki Tuzlali; Deniz Guzey; Semra Dolek Guler; Seniha Hacihanefioglu; Nejat Dalay
- Publisher
- Springer Netherlands
- Year
- 2007
- Tongue
- English
- Weight
- 200 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1219-4956
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Fluorescence in situ hybridization (fish) is the gold standard for assessing her-2 status for breast cancers, and paraffin-embedded tissue sections are used routinely for her-2 fish. cytologic samples also are used, but to the authors' knowledge, little is known regarding the reliabi
## Abstract Chromosomal instability (CIN) is a common cause of tumour heterogeneity and poor prognosis in solid tumours and describes cellβcell variation in chromosome structure or number across a tumour population. In this article we consider evidence suggesting that CIN may be targeted and may in
## Abstract Treatment success of breast cancer patients with trastuzumab alone or in combination depends not only on __HER2/NEU__ amplification but also on __PTEN__ and PI3K status and efficient cell death programs. In this pilot study, we found a significant association between loss of __beclin 1_
## Abstract ## BACKGROUND: The current study was performed to determine the impact of polysomy 17 on the interpretation of __HER2__ testing of invasive breast carcinomas using fluorescent in situ hybridization methods. Current American Society of Clinical Oncology/College of American Pathologists